Published in Br J Clin Pharmacol on December 01, 2005
Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clin Pharmacol (2009) 2.14
An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting among prescribers at a tertiary care hospital. Perspect Clin Res (2011) 1.72
Pharmacovigilance in Italy: An overview. J Pharmacol Pharmacother (2013) 1.59
A qualitative exploration of the major challenges facing pharmacovigilance in Saudi Arabia. Saudi Med J (2015) 1.45
Pharmacy students' knowledge and perceptions about pharmacovigilance in Malaysian public universities. Am J Pharm Educ (2011) 1.28
Improvement of knowledge, attitude and perception of healthcare workers about ADR, a pre- and post-clinical pharmacists' interventional study. BMJ Open (2012) 1.14
Knowledge, attitudes, and practice of doctors to adverse drug reaction reporting in a teaching hospital in India: An observational study. J Nat Sci Biol Med (2013) 1.14
Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature. BMC Med (2016) 1.11
Knowledge, attitudes and practice of nurse regarding adverse drug reaction reporting. Iran J Nurs Midwifery Res (2012) 1.01
Limitations and obstacles of the spontaneous adverse drugs reactions reporting: Two "challenging" case reports. J Pharmacol Pharmacother (2013) 1.01
Spontaneously reported hepatic adverse drug events in Korea: multicenter study. J Korean Med Sci (2012) 0.95
Pharmacy students' attitudes toward reporting serious adverse drug events. Am J Pharm Educ (2012) 0.91
Reporting of adverse drug reactions: an exploratory study among nurses in a teaching hospital, Ajman, United Arab Emirates. Daru (2012) 0.90
Educational sessions in pharmacovigilance: What do the doctors think? BMC Res Notes (2010) 0.85
Effect of an intervention on the features of adverse drug reactions spontaneously reported in a hospital. Eur J Clin Pharmacol (2010) 0.85
What can we learn from parents about enhancing participation in pharmacovigilance? Br J Clin Pharmacol (2013) 0.84
Biomarkers, metabonomics, and drug development: can inborn errors of metabolism help in understanding drug toxicity? AAPS J (2007) 0.82
Knowledge, perception and practice of pharmacovigilance among community pharmacists in South India. Pharm Pract (Granada) (2012) 0.81
Knowledge, attitude and practices toward pharmacovigilance and adverse drug reactions in postgraduate students of Tertiary Care Hospital in Gujarat. J Adv Pharm Technol Res (2015) 0.81
Multidisciplinary approach to improve spontaneous ADR reporting in the pediatric outpatient setting: a single-institute experience in Korea. Springerplus (2016) 0.78
Perceived barriers to reporting adverse drug events in hospitals: a qualitative study using theoretical domains framework approach. Implement Sci (2015) 0.78
A comparison of active surveillance programs including a spontaneous reporting model for phamacovigilance of adverse drug events in a hospital. Korean J Intern Med (2012) 0.75
Predictive Factors of Spontaneous Reporting of Adverse Drug Reactions among Community Pharmacists. PLoS One (2016) 0.75
Factors Influencing the Use of a Mobile App for Reporting Adverse Drug Reactions and Receiving Safety Information: A Qualitative Study. Drug Saf (2016) 0.75
Adverse reactions to fluoroquinolones in the Nigerian population: an audit of reports submitted to the National Pharmacovigilance Centre from 2004 to 2016. Pharmacol Res Perspect (2017) 0.75
Perception on adverse drug reaction reporting by physicians working in southern romania. Maedica (Buchar) (2013) 0.75
Information and feedback to improve occupational physicians' reporting of occupational diseases: a randomised controlled trial. Int Arch Occup Environ Health (2009) 0.75
Public awareness and perception toward Adverse Drug Reactions reporting in Riyadh, Saudi Arabia. Saudi Pharm J (2017) 0.75
Adverse Drug Reaction Reporting Practices Among United Arab Emirates Pharmacists and Prescribers. Hosp Pharm (2017) 0.75
The Impact of the Educational Intervention on Knowledge, Attitude, and Practice of Pharmacovigilance toward Adverse Drug Reactions Reporting among Health-care Professionals in a Tertiary Care Hospital in South India. J Nat Sci Biol Med (2017) 0.75
Qualitative research. Introducing focus groups. BMJ (1995) 25.85
Rigour and qualitative research. BMJ (1995) 22.49
Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. Br J Clin Pharmacol (1995) 4.72
Pharmacovigilance: paradise lost, regained or postponed? The William Withering Lecture 1994. J R Coll Physicians Lond (1995) 4.55
Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. The European Pharmacovigilance Research Group. Eur J Clin Pharmacol (1997) 2.80
Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol (1999) 2.78
Attitudes to adverse drug reaction reporting in the Northern Region. Br J Clin Pharmacol (1992) 2.51
Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. J Clin Epidemiol (2002) 1.93
Attitudes to reporting adverse drug reactions in northern Sweden. Eur J Clin Pharmacol (2000) 1.72
Reasons for reporting adverse drug reactions--some thoughts based on an international review. Pharmacoepidemiol Drug Saf (1997) 1.36
Reporting of adverse drug reactions by hospital doctors and the response to intervention. Br J Clin Pharmacol (1997) 1.28
150 years of pharmacovigilance. Lancet (1998) 1.16
Physicians' attitudes towards voluntary reporting of adverse drug events. J Eval Clin Pract (2001) 0.99
[The use of antibiotics in surgical prophylaxis. The characteristics and consequences]. Med Clin (Barc) (1993) 2.68
Daytime sleepiness and polysomnographic variables in sleep apnoea patients. Eur Respir J (2007) 2.61
Hypothesis: does COPD have an autoimmune component? Thorax (2003) 1.98
Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study. J Am Coll Cardiol (1996) 1.83
Beta-adrenergic blocking agents in heart failure: benefits of vasodilating and non-vasodilating agents according to patients' characteristics: a meta-analysis of clinical trials. Arch Intern Med (2000) 1.62
MR imaging of synovial tumors and tumor-like lesions. Eur Radiol (2001) 1.62
Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trial. Thorax (2008) 1.42
Medical speciality and pattern of medicines prescription. Eur J Clin Pharmacol (2004) 1.40
[The characteristics of digoxin utilization in a population under emergency care for heart failure or auricular fibrillation]. Med Clin (Barc) (1993) 1.39
[The decree on selective drug financing in charge of the Social Security]. Med Clin (Barc) (1993) 1.39
Nuclear IKK activity leads to dysregulated notch-dependent gene expression in colorectal cancer. Proc Natl Acad Sci U S A (2006) 1.36
MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemia. Leukemia (2013) 1.30
[Profile of self-medication in Brazil]. Rev Saude Publica (1997) 1.21
The potential impact of anaemia of chronic disease in COPD. Eur Respir J (2006) 1.15
Magnetic resonance imaging of pyomyositis in 43 cases. Eur J Radiol (2000) 1.14
Variability and effects of bronchial colonisation in patients with moderate COPD. Eur Respir J (2009) 1.04
Painful heel: MR imaging findings. Radiographics (2000) 1.02
Trends of prescribing patterns for the secondary prevention of myocardial infarction over a 13-year period. Eur J Clin Pharmacol (1998) 1.02
Immunophenotypic analysis of Waldenstrom's macroglobulinemia. Semin Oncol (2003) 1.01
Abnormal mitochondrial function in locomotor and respiratory muscles of COPD patients. Eur Respir J (2009) 1.00
Changes in the photosynthetic light response curve during leaf development of field grown maize with implications for modelling canopy photosynthesis. Photosynth Res (1994) 0.99
Kaposi's sarcoma and toxoplasma gondii brain abscess in a Spanish homosexual. Lancet (1982) 0.97
[The eye and acromegaly: apropos of a case of ptosis]. Bull Soc Belge Ophtalmol (1992) 0.97
Role of the BRAF mutations in the microsatellite instability genetic pathway in sporadic colorectal cancer. Ann Surg Oncol (2006) 0.92
Proton MR spectroscopy improves discrimination between tumor and pseudotumoral lesion in solid brain masses. AJNR Am J Neuroradiol (2008) 0.90
Fluticasone propionate reduces bacterial airway epithelial invasion. Eur Respir J (2008) 0.89
Pelvic arteriovenous malformation as a rare cause of sciatica. Br J Rheumatol (1997) 0.88
6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosis. Br J Haematol (2007) 0.88
Therapeutic consultation: a necessary adjunct to independent drug information. Br J Clin Pharmacol (1993) 0.88
Intraventricular meningiomas: MR imaging and MR spectroscopic findings in two cases. AJNR Am J Neuroradiol (1999) 0.86
Epidemiology of Cryptosporidium molnari in Spanish gilthead sea bream (Sparus aurata L.) and European sea bass (Dicentrarchus labrax L.) cultures: from hatchery to market size. Appl Environ Microbiol (2005) 0.85
Intraventricular ganglioglioma: case report. Neuroradiology (1998) 0.83
Management of postoperative pain in abdominal surgery in Spain. A multicentre drug utilization study. Br J Clin Pharmacol (1999) 0.83
Utility of proton MR spectroscopy in the diagnosis of radiologically atypical intracranial meningiomas. Neuroradiology (2003) 0.83
Yersinia enterocolitica O:8 and O:5 lipopolysaccharide arthritogenicity in hamsters. Rheumatology (Oxford) (2000) 0.82
[Therapeutic consultation: information oriented to clinical problems]. Rev Clin Esp (1989) 0.82
Available evidence and outcome of off-label use of rituximab in clinical practice. Eur J Clin Pharmacol (2013) 0.82
Proton MR spectroscopy provides relevant prognostic information in high-grade astrocytomas. AJNR Am J Neuroradiol (2010) 0.82
Chronic liver disease in patients with lymphoma. Gastroenterol Clin Biol (1983) 0.82
[Myopathy secondary to the treatment with inhibitors of HMG-CoA reductase]. Med Clin (Barc) (1998) 0.82
DNase use in the daily care of cystic fibrosis: who benefits from it and to what extent? Results of a cohort study of 199 patients in 13 centres. DNase National Study Group. Eur J Pediatr (2000) 0.82
Meningeal involvement in Behçet's disease: MRI. Neuroradiology (1998) 0.81
Avoiding confusion in COPD: from risk factors to phenotypes to measures of disease characterisation. Eur Respir J (2011) 0.81
Outcomes of off-label drug uses in hospitals: a multicentric prospective study. Eur J Clin Pharmacol (2014) 0.81
[Acceptance of generic prescribing in general practice: effect of patient education and reference prices]. Gac Sanit (2002) 0.81
Analgesics for pain after traumatic or orthopaedic surgery: what is the evidence--a systematic review. Eur J Clin Pharmacol (2006) 0.81
A randomized, double-blind, placebo-controlled trial comparing pethidine to metamizol for treatment of post-anaesthetic shivering. Br J Clin Pharmacol (1996) 0.81
[A program for the detection of adverse reactions to drugs in hospitalized patients. Methods and results of the pilot phase]. Med Clin (Barc) (1984) 0.80
Infectious endocarditis due to Yersinia enterocolitica. J Infect Dis (1983) 0.79
Recurring tracheal leiomyoma presenting as a calcified mediastinal mass. Eur J Radiol (1996) 0.79
[Determination of the distribution of ventilation-perfusion ratios: technic of elimination of multiple inert gases]. Rev Esp Fisiol (1986) 0.78
An ethanolic-aqueous extract of Curcuma longa decreases the susceptibility of liver microsomes and mitochondria to lipid peroxidation in atherosclerotic rabbits. Biofactors (1998) 0.78
Differential modulation of the glutamate-nitric oxide-cyclic GMP pathway by distinct neurosteroids in cerebellum in vivo. Neuroscience (2011) 0.78
Evaluation of tumor marker S-100 in cerebrospinal fluid from subjects with nonischemic brain pathologies. Tumour Biol (2000) 0.78
Meta-analysis of passive immunoprophylaxis in paediatric patients at risk of severe RSV infection. Acta Paediatr (2010) 0.78
Intraventricular mass lesions of the brain. Eur Radiol (2000) 0.78
Targeting striatal metabotropic glutamate receptor type 5 in Parkinson's disease: bridging molecular studies and clinical trials. CNS Neurol Disord Drug Targets (2013) 0.78
The yin and yang of COPD: or balancing repair (yang) and inflammation (yin). Eur Respir J (2008) 0.78
Multicentre hospital drug utilization study on the prophylaxis of venous thromboembolism. The Venous Thromboembolism Study Group of the Spanish Society of Clinical Pharmacology. Br J Clin Pharmacol (1994) 0.78
From clinical trials to clinical practice: oral anticoagulation among patients with non-rheumatic, atrial fibrillation. Eur J Clin Pharmacol (1997) 0.77
A carbohydrate-rich diet reduces LDL size in QQ homozygotes for the Gln 192Arg polymorphism of the paraoxonase 1 gene. Lipids (2005) 0.77
Clinical trials versus clinical practice in the secondary prevention of myocardial infarction. Eur J Clin Pharmacol (1994) 0.77
[Analgesics in the postoperative period of abdominal interventions. The Study Group on Postoperative Analgesia of the Spanish Society of Clinical Pharmacology]. Med Clin (Barc) (1997) 0.77
Inflammatory Asthma Phenotype Discrimination Using an Electronic Nose Breath Analyzer. J Investig Allergol Clin Immunol (2015) 0.77
Spermatocytic seminoma: sonographic appearance. J Ultrasound Med (1996) 0.77
beta3-Adrenergic receptor Trp64Arg polymorphism and increased body mass index in sleep apnoea. Eur Respir J (2007) 0.76
Intranasal immunization with Yersinia enterocolitica O:8 cellular extract protects against local challenge infection. Microbiol Immunol (1998) 0.76
MRI of mediastinal parathyroid cystic adenoma causing hyperparathyroidism. J Comput Assist Tomogr (1996) 0.75
[Use of levofloxacin in the hospital]. Rev Esp Quimioter (2003) 0.75
Megakaryocytes in serous effusions. J Clin Pathol (1981) 0.75
Aspirin, ticlopidine, and stroke. Lancet (1989) 0.75
Secondary prophylaxis against myocardial infarction. BMJ (1991) 0.75
Central and extrapontine myelinolysis following allogeneic peripheral haematopoietic progenitor cell transplantation. Favourable outcome in a patient with chronic myeloid leukaemia. Bone Marrow Transplant (2003) 0.75
[Safety of quinolones administration in children?]. Med Clin (Barc) (2001) 0.75
[Electromyographic characteristics of postanesthetic tremor]. Rev Esp Anestesiol Reanim (1997) 0.75
Is aspirin underused in myocardial infarction? Pharmacoeconomics (1997) 0.75
[Intrahospital pneumonias. Etiological diagnosis by transtracheal aspiration puncture]. Med Clin (Barc) (1983) 0.75
[Research on drug utilization in primary health care in national journals]. Aten Primaria (1991) 0.75
[Primary lung tumors. Clinical and histopathological characteristics and course in 307 patients]. Rev Clin Esp (1985) 0.75
[Utilization of thrombolytic drugs in Barcelona. Study Group on Secondary Prevention of Myocardial Infarction]. Med Clin (Barc) (1997) 0.75
[Diaphragmatic paralysis in cervical herpes zoster]. Enferm Infecc Microbiol Clin (1991) 0.75
[Informed consent and clinical trial committees]. Med Clin (Barc) (1990) 0.75
[The safety of the derivatives of retinoic acid administered topically during pregnancy]. Med Clin (Barc) (1999) 0.75
[Diffuse alveoloseptal amyloidosis. Apropos of a case]. Med Clin (Barc) (1983) 0.75
[Antibody-coated bacteria in the sputum from patients with pneumococcal pneumonia]. Enferm Infecc Microbiol Clin (1989) 0.75
[Therapeutic consultation: clinical pharmacology, knowledge update, and treatment individualization]. Med Clin (Barc) (1998) 0.75
[Clinical and bacteriological aspects of purulent pericarditis (author's transl)]. Med Clin (Barc) (1980) 0.75
[Clear-fluid meningitis in a patient with boutonneuse fever]. Enferm Infecc Microbiol Clin (1993) 0.75
[Death from asthma. Analysis of 21 cases]. Med Clin (Barc) (1986) 0.75
[Efficacy of oral adrenergic beta blockers in the treatment of glaucoma]. Med Clin (Barc) (1998) 0.75
[Endoscopic characteristics of bronchopulmonary carcinomas. Study of 226 endoscopies]. Rev Clin Esp (1986) 0.75
[Anticoagulation in aged patients with chronic non-rheumatic atrial fibrillation]. Med Clin (Barc) (1999) 0.75
The I antigen as an immune complex receptor in a case of haemolytic anaemia induced by an antihistaminic agent. Br J Haematol (1981) 0.75
[Tocolytic treatment of premature labor]. Med Clin (Barc) (2001) 0.75